Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers
MORRISVILLE, N.C., May 19, 2022 -- (Healthcare Sales & Marketing Network) -- Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the closing of a $37 million Series A financing led by Kineticos Ve... Biopharmaceuticals, Venture Capital Inceptor Bio (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 19, 2022 Category: Pharmaceuticals Source Type: news

Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
ROCHESTER, Minn., May 17, 2022 -- (Healthcare Sales & Marketing Network) -- Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced $29.5M in new funding led by Mr. Harry ... Biopharmaceuticals, Oncology, Venture Capital Vyriad, oncolytic virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2022 Category: Pharmaceuticals Source Type: news

Remix Therapeutics Closes $70 Million Series B Financing
Supports Novel Small Molecule Therapeutic Approach Designed to Reprogram RNA Processing and Modulate Gene Expression CAMBRIDGE, Mass., May 17, 2022 -- (Healthcare Sales & Marketing Network) -- Remix Therapeutics (Remix), a biotechnology company develop... Biopharmaceuticals, Venture Capital Remix Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2022 Category: Pharmaceuticals Source Type: news

Mirvie Raises $60 Million For Blood Test To Predict Pregnancy Complications
Cofounders Maneesh Jain and Stephen Quake are applying liquid biopsy, a non-invasive diagnostic technology better known for cancer screening, to pregnancy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 17, 2022 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Science /science Leadership /leadership ForbesWomen /forbeswomen Editors' Pick editors-pick Source Type: news

Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board
Proceeds will be used to advance clinical program of GNSC-001, company's lead candidate in osteoarthritis (OA) Brian Kotzin, M.D., and Jackson Streeter, M.D., join Genascence's board of directors Company expands Scientific Advisory Board of internati... Regenerative Medicine, Orthopaedic, Venture Capital Genascence, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2022 Category: Pharmaceuticals Source Type: news

SimpliFed Raises $6 Million In Latest Seed Round
This funding will help expand the telehealth startup ’s initiative dedicated to providing virtual lactation services to military families. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 10, 2022 Category: Pharmaceuticals Authors: Ariyana Griffin, Forbes Staff Tags: Diversity, Equity & Inclusion /diversity-equity-inclusion Leadership /leadership Innovation /innovation Venture Capital /venture-capital Healthcare /healthcare Source Type: news

One region ’s top-funded startups closes $7M loan from Silicon Valley Bank
One of Greater Cincinnati ’s best-funded startups has secured a $7 million debt facility from a stalwart in the venture capital community. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 9, 2022 Category: Biotechnology Authors: Liz Engel Source Type: news

BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
RENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of OAB. PARK CITY, Utah and HERZLIYA, Israel, May 9, 2022 -- (Healthcare Sales & Marketing Network) -- BlueWind... Devices, Urology, Venture Capital BlueWind Medical, ConvaTec , RENOVA iStim, neuromodulation, OAB (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2022 Category: Pharmaceuticals Source Type: news

XII Medical Completes $30 Million Series A Financing
World-class investor syndicate supports best-in-class, patient-centric solution for obstructive sleep apnea UNION CITY, Calif., May 5, 2022 -- (Healthcare Sales & Marketing Network) -- XII Medical, Inc., a private health technology company, today annou... Devices, Venture Capital XII Medical, obstructive sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 5, 2022 Category: Pharmaceuticals Source Type: news

VideaHealth Dental AI Solution Receives FDA 510(k) Clearance, Establishing Industry-wide Benchmark for Clinical Accuracy
 VideaHealth Dental AI Solution Receives FDA 510(k) Clearance, Establishing Industry-wide Benchmark for Clinical AccuracyCompany ushers in a new era of transparency and efficiency by bringing to market the most diverse AI dental imaging dataset in the industryBOSTON, May 2, 2022–VideaHealth, a dental AI pioneer, today announced the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance for Videa Caries Assist, an AI-powered dental caries (cavity) detection algorithm. VideaHealth surpassed the FDA ’s exacting efficacy requirements by significantly aiding the analysis of radiographs instantly from the d...
Source: Dental Technology Blog - May 4, 2022 Category: Dentistry Source Type: news

Aiming to treat the 'whole woman,' medical startup opens HQ, 1st Bay Area office with UCSF
The company, which has attracted some $130 million in venture capital, opened its flagship clinic and headquarters in San Francisco. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 3, 2022 Category: American Health Authors: Ron Leuty Source Type: news

Aiming to treat the 'whole woman,' medical startup opens 1st Bay Area office with UCSF
The company, which has attracted some $130 million in venture capital, opened its flagship clinic and headquarters in San Francisco. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 2, 2022 Category: Biotechnology Authors: Ron Leuty Source Type: news

Health care tech VC firm Flare Capital Partners closes oversubscribed third fund
Flare Capital Partners, an eight-year-old venture capital firm focusing on health care technology, oversubscribed its third fund by $100 million. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 27, 2022 Category: American Health Authors: Hannah Green Source Type: news

More Disruption, Please
An article in the Wall Street Journal from last year makes the case for consolidation among employer-focused digital health solutions, for example, citing the “enough already” attitude from buyers when it comes to the seemingly never-ending parade of redundant, overpriced options in the marketplace. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 27, 2022 Category: Pharmaceuticals Authors: Seth Joseph, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Source Type: news

Health AI Startup Biofourmis Hits $1.3 Billion Valuation With Series D Funding
Omar Ishrak, chairperson of Intel and former CEO of Medtronic, will join the company ’s board as it scales up digital therapeutics trials and care at home programs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 26, 2022 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Editors' Pick editors-pick Source Type: news